These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2114020)

  • 1. Formulation and in vitro-in vivo evaluation of sustained-release lithium carbonate tablets.
    Ciftçi K; Capan Y; Oztürk O; Hincal AA
    Pharm Res; 1990 Apr; 7(4):359-63. PubMed ID: 2114020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation of sustained - release lithium carbonate matrix tablets: influence of hydrophilic materials on the release rate and in vitro-in vivo evaluation.
    Emami J; Tavakoli N; Movahedian A
    J Pharm Pharm Sci; 2004 Nov; 7(3):338-44. PubMed ID: 15576014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A comparative analysis of the influence of different types of Carbopol on the release rate of lithium-carbonate from matrix tablets].
    Toskić-Radojcić M; Pavlović M; Gazikalović E; Arandjelović A; Kovacević A
    Vojnosanit Pregl; 2012 Aug; 69(8):675-80. PubMed ID: 22924263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation, bioavailability, and pharmacokinetics of sustained-release potassium chloride tablets.
    Senel S; Capan Y; Dalkara T; Inanç N; Hincal AA
    Pharm Res; 1991 Oct; 8(10):1313-7. PubMed ID: 1796051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the in vitro and in vivo performance of two sustained-release lithium carbonate matrix tablets. Effect of different diets on the bioavailability.
    Gai MN; Ferj S; García E; Seitz C; Thielemann AM; Andonaegui MT
    Drug Dev Ind Pharm; 1999 Feb; 25(2):131-40. PubMed ID: 10065346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained release isoniazid tablets. I--Formulation and in vitro evaluation.
    Bulut-Oner F; Capan Y; Kas S; Oner L; Hincal AA
    Farmaco; 1989; 44(7-8):739-52. PubMed ID: 2590371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and evaluation of sustained-release tablets of lithium in a fat matrix and its bioavailability in humans.
    Llabrés M; Fariña JB
    J Pharm Sci; 1991 Nov; 80(11):1012-6. PubMed ID: 1815050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steady-state lithium blood level fluctuations in man following administration of a lithium carbonate conventional and controlled-release dosage form.
    Caldwell HC; Westlake WJ; Schriver RC; Bumbier EE
    J Clin Pharmacol; 1981; 21(2):106-9. PubMed ID: 6785324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability of lithium from lithium citrate syrup versus conventional lithium carbonate tablets.
    Guelen PJ; Janssen TJ; De Witte TC; Vree TB; Benson K
    Biopharm Drug Dispos; 1992 Oct; 13(7):503-11. PubMed ID: 1489941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absorption of lithium following administration of slow-release and conventional preparations.
    Tyrer S; Hullin RP; Birch NJ; Goodwin JC
    Psychol Med; 1976 Feb; 6(1):51-8. PubMed ID: 935297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and pharmacokinetics study on gastro-floating sustained-release tablets of troxipide.
    Gao Y; Gao Y; Yin F; Wang M; Wang Z; Ye T; Yang Y; Pan WS; Yang X
    Drug Dev Ind Pharm; 2015; 41(9):1443-51. PubMed ID: 25190152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absorption and disposition kinetics of lithium carbonate following administration of conventional and controlled release formulations.
    Arancibia A; Corvalan F; Mella F; Concha L
    Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):240-5. PubMed ID: 3089949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of media and other variables on the BP solution rate test for slow lithium carbonate tablets.
    Wall BP; Parkin JE; Sunderland VB
    J Pharm Pharmacol; 1986 Sep; 38(9):633-7. PubMed ID: 2877060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
    Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
    Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation, development, and performance evaluation of metoclopramide HCl oro-dispersible sustained release tablet.
    Kasliwal N; Negi JS; Jugran V; Jain R
    Arch Pharm Res; 2011 Oct; 34(10):1691-700. PubMed ID: 22076769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting the formulation of sustained release potassium chloride tablets.
    Senel S; Capan Y; Hincal AA
    Pharmazie; 1991 Nov; 46(11):792-5. PubMed ID: 1811230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability of lithium carbonate and lithium citrate: a comparison of two controlled-release preparations.
    Tyrer SP; Peat MA; Minty PS; Luchini A; Glud V; Amdisen A
    Pharmatherapeutica; 1982; 3(4):243-6. PubMed ID: 6815664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of mixture experimental design in the formulation and optimization of matrix tablets containing carbomer and hydroxy-propylmethylcellulose.
    Petrovic A; Cvetkovic N; Ibric S; Trajkovic S; Djuric Z; Popadic D; Popovic R
    Arch Pharm Res; 2009 Dec; 32(12):1767-74. PubMed ID: 20162406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of side effects with coated lithium carbonate tablets and lithium sulphate preparations giving medium-slow and slow-release.
    Edström A; Persson G
    Acta Psychiatr Scand; 1977 Feb; 55(2):153-8. PubMed ID: 320832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.